Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: Mol Cancer Ther. 2024 Oct 1;23(10):1378–1388. doi: 10.1158/1535-7163.MCT-23-0519

Table 2.

Publicly available co-structures with KRAS and an inhibitory molecule

PDB ID KRAS mutant Nucleotide Inhibitory molecule
8AZV KRASWT GDP BI-2865
8TBF KRASWT GNP RMC-7977 + CypA
5F2E KRASG12C GDP ARS-583
5V9U KRASG12C GDP ARS-1620
6B0V KRASG12C GDP ARS-107
6B0Y KRASG12C GDP ARS-917
6OIM KRASG12C GDP AMG 510
6USX KRASG12C GDP MRTX849
5YXZ KRASG12C GDP JBI484
5YY1 KRASG12C GDP JBI739
7R0M KRASG12C GDP JDQ443
8AZX KRASG12C GDP BI-2865
8G9P KRASG12C GNP RMC-4998 + CypA
8TBK KRASG12C GNP RMC-7977 + CypA
8JGD KRASG12C GDP YK-8S
8DNI KRASG12C GDP Araxes WO2020/028706A1 compound I-1
7ACA KRASG12D GPPCP BI-5747
7T47 KRASG12D GPPCP MRTX1133
8TBL KRASG12D GNP RMC-7977 + CypA
8TBJ KRASG12R GNP RMC-7977 + CypA
8TBN KRASG12S GNP RMC-7977 + CypA
8AZZ KRASG12V GDP BI-2865
8TBM KRASG12V GNP RMC-7977 + CypA
8B00 KRASG13D GDP BI-2865
8ONV KRASG13D GDP BI-2493

CypA – Cyclophilin A. GDP – guanosine diphosphate. GNP – phosphoaminophosphonic acid-guanylate ester. GPPCP – Guanosine-5′-[(β,γ)-methyleno]triphosphate.